Hexanoyl Therapeutics Private Limited
About Hexanoyl Therapeutics Private Limited
Data last updated:
Hexanoyl Therapeutics Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 05 September 2016.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2016PTC111814.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Chromo Pharma Tech Private Limited. It was led by directors Praveen Kumar Reddy Bommareddy and Bomma Reddy Ananda Reddy.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at H No.20 – 41/60/104 Flat No 104 Mathrusri Homes Miyapur X Roads Miyapur, Hyderabad, Telangana, India – 500049.
Company details
Contact details
Hexanoyl Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH No.20 – 41/60/104 Flat No 104 Mathrusri Homes Miyapur X Roads Miyapur, Hyderabad, Telangana, India – 500049
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Hexanoyl Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hexanoyl Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Hexanoyl Therapeutics Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Hexanoyl Therapeutics Private Limited, buy the company report.
Board of directors of Hexanoyl Therapeutics Private Limited
Hexanoyl Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar Reddy Bommareddy Also directs: Hexanoyl Life Sciences LLP | Director | 12 Feb 2019 | 7 Years 8 Months | As last reported |
| Bomma Reddy Ananda Reddy Also directs: SBR Pharma Chem LLP, Chromo Life Sciences Private Limited, Chromo Laboratories India Private Limited and 2 more | Director | 05 Sep 2016 | 10 Years 2 Months | As last reported |
Shareholding
The shareholding of Hexanoyl Therapeutics Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Hexanoyl Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hexanoyl Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hexanoyl Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hexanoyl Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hexanoyl Therapeutics Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Kurada Naga Sreedhar ceased to be Director on 21 Feb 2019.
Frequently asked questions
Hexanoyl Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Hexanoyl Therapeutics was a private limited company based in Hyderabad, Telangana, India. The company worked in other wholesale, within the trading industry. It was incorporated on 05 September 2016 and is registered under CIN U24239TG2016PTC111814. The company has been struck off by the Registrar of Companies and is no longer operational.
Hexanoyl Therapeutics had 2 directors:
- Praveen Kumar Reddy Bommareddy - Director
- Bomma Reddy Ananda Reddy - Director
The CIN (Corporate Identification Number) of Hexanoyl Therapeutics is U24239TG2016PTC111814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Hexanoyl Therapeutics is at H No.20 – 4160104 Flat No 104 Mathrusri Homes Miyapur X Roads Miyapur, Hyderabad, Telangana, India – 500049.
Hexanoyl Therapeutics was incorporated on 05 September 2016. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Hexanoyl Therapeutics on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
Hexanoyl Therapeutics operated in the trading industry, in the other wholesale segment. It worked in this industry before it was struck off.
Kurada Naga Sreedhar ceased to be Director on 21 Feb 2019. Praveen Kumar Reddy Bommareddy was appointed as Director on 12 Feb 2019. Bomma Reddy Ananda Reddy was appointed as Director on 05 Sep 2016.
The compliance status of Hexanoyl Therapeutics is compliant as of 05 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
